North America Peripheral Embolization Coils Market Forecast to 2031 - Regional Analysis

Description

List of Tables

The North America peripheral embolization coils market was valued at US$ 247.86 million in 2023 and is expected to reach US$ 360.53 million by 2031; it is estimated to register a CAGR of 4.8% from 2023 to 2031.

Rise in Prevalence of Aortic Aneurysm Loss Fuels North America Peripheral Embolization Coils Market

An aortic aneurysm is a bulging wall of the body's major artery or aorta. According to the American Heart Association's 2023 data, aortic aneurysms were the cause of 150,000 fatalities reported across the world in 2020, indicating a 26% rise from 2010. Smokers and women had greater rates of aneurysmal rupture. Currently, there are no effective medications to prevent the development of aortic aneurysms; the only treatment options are surgical or endovascular repair. Embolization agents are frequently used as substitutes for open surgeries, which are riskier and followed by longer recovery periods. Peripheral vascular embolization coils, cyanoacrylate or fibrin glue, gel foam, and Onyx are among the embolic devices that are commonly used to treat endoleaks from aortic aneurysms. Coiling is a suitable therapy option for peripheral aneurysms since it is less invasive than open surgical repair. Coils can also be used in elective settings to treat some congenital cardiac diseases, fistulas, aneurysms, and arterial side branch steal syndrome after coronary artery bypass grafting. Therefore, an upsurge in the prevalence of aortic aneurysms drives the growth of the peripheral embolization coils market.

North America Peripheral Embolization Coils Market Overview

The peripheral embolization coils market in North America has been analyzed based on the market scenarios in United States, Canada and Mexico. An upsurge in the prevalence of colorectal cancer and trauma is a prime factor propelling market growth in this region. Colorectal cancer is the fourth most prevalent cancer in Mexico, with most cases reported after the age of 50, with a comparable distribution of cases in both genders. As a result, the number of new cases and rate of mortality have steadily climbed alongside the rising life expectancy. The peripheral embolization coil market in the United States is experiencing growth due to the increasing prevalence of vascular diseases, such as peripheral artery disease (PAD) and aneurysms, requiring minimally invasive treatment options. Peripheral embolization coils are essential for including blood vessels to prevent hemorrhage or reduce blood flow in targeted areas. As healthcare providers focus on improving patient outcomes with less invasive procedures, the demand for these coils is rising. Technological advancements, such as the development of more efficient and biocompatible coils, along with growing awareness of endovascular treatments, are further driving market expansion in the United States.

Cancer incidences are rising in Mexico, and colorectal cancer is ranked as the third most frequently diagnosed cancer. According to IMSS, every year approximately 15,000 new cases are registered with colon cancer in the country. The market for colorectal cancer in Mexico is expected to grow to increase the campaign for early detection of cancers. According to GLOBOCAN, in Mexico, the incidence rate of gastric cancer was 6.2% in 2020, with a mortality rate of 4.7 per 100,000 persons. Microcoil embolization is a well-established treatment for upper gastrointestinal bleeding that can be performed closer to the bleeding site. The procedure performed using a superselective catheter is a safe and effective way of managing acute lower gastrointestinal bleeding. According to Statista, trauma was the reason for ~600 per 100,000 hospitalizations in Canada in 2021. According to an article published by the Canadian Journal of Surgery (CJS) in 2021, transarterial embolization procedures are successfully being used to treat non-splenic traumatic injuries; the most common embolization technique is coiling with gel foam. These procedures have high success rates with low rates of complications. Moreover, Health Canada has approved numerous coils and coil delivery systems for the treatment of intracranial aneurysms. Coil embolization is used with other adjunct endovascular devices, such as stents and balloons.

North America Peripheral Embolization Coils Market Revenue and Forecast to 2031 (US$ Million)

North America Peripheral Embolization Coils Market Segmentation

The North America peripheral embolization coils market is categorized into type, material, application, and country.

Based on type, the North America peripheral embolization coils market is bifurcated into detachable coil and pushable coil. The detachable coil segment held a larger market share in 2023.

In terms of material, the North America peripheral embolization coils market is categorized into platinum, platinum & hydrogel, and platinum tungsten alloy. The platinum segment held the largest market share in 2023.

By application, the North America peripheral embolization coils market is segmented into bleedings & trauma, malformations, tumours, visceral aneurysm, endoleak type II, and varicose veins. The bleedings & trauma segment held the largest market share in 2023.

Based on country, the North America peripheral embolization coils market is segmented into the US, Canada, and Mexico. The US dominated the North America peripheral embolization coils market share in 2023.

Medtronic Plc; Penumbra, Inc.; Balt; Boston Scientific Corp; Cook Medical Holdings LLC; Wallaby Medical; Spartan Micro Inc.; and Terumo Corp. are some of the leading companies operating in the North America peripheral embolization coils market.

Product Code: BMIRE00031510

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. North America Peripheral Embolization Coils Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Rise in Prevalence of Aortic Aneurysm
- 4.1.2 Increase in Incidence of Cancer
4.2 Market Restraints
- 4.2.1 Complications Arising During or After Embolization
4.3 Market Opportunities
- 4.3.1 Expanding Range of Applications of Embolization Coils
4.4 Future Trends
- 4.4.1 Growing Importance of Packing Density
4.5 Impact of Drivers and Restraints:

5. Peripheral Embolization Coils Market - North America Analysis

5.1 North America Peripheral Embolization Coils Market Overview
5.2 Peripheral Embolization Coils Market Revenue (US$ Million), 2021-2031
5.3 Peripheral Embolization Coils Market Forecast Analysis
5.4 Peripheral Embolization Coils Market: Company Positioning

6. North America Peripheral Embolization Coils Market Analysis - by Product Type

6.1 Overview
6.2 Detachable Coil
- 6.2.1 Overview
- 6.2.2 Detachable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
6.3 Pushable Coil
- 6.3.1 Overview
- 6.3.2 Pushable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

7. North America Peripheral Embolization Coils Market Analysis - by Material

7.1 Overview
7.2 Platinum
- 7.2.1 Overview
- 7.2.2 Platinum: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Platinum & Hydrogel
- 7.3.1 Overview
- 7.3.2 Platinum & Hydrogel: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Platinum Tungsten Alloy
- 7.4.1 Overview
- 7.4.2 Platinum Tungsten Alloy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Peripheral Embolization Coils Market Analysis - by Application

8.1 Overview
8.2 Bleedings & Trauma
- 8.2.1 Overview
- 8.2.2 Bleedings & Trauma: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Malformations
- 8.3.1 Overview
- 8.3.2 Malformations: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Tumors
- 8.4.1 Overview
- 8.4.2 Tumors: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Visceral Aneurysms
- 8.5.1 Overview
- 8.5.2 Visceral Aneurysms: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Endoleak Type II
- 8.6.1 Overview
- 8.6.2 Endoleak Type II: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.7 Varicose Veins
- 8.7.1 Overview
- 8.7.2 Varicose Veins: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Peripheral Embolization Coils Market - Country Analysis

9.1 North America Overview
- 9.1.1 North America: Peripheral Embolization Coils Market Breakdown, by Key Country, 2023 and 2031 (%)
  - 9.1.1.1 United States: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.1.1 United States: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.1.2 United States: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.1.3 United States: Peripheral Embolization Coils Market Breakdown, by Application
  - 9.1.1.2 Canada: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.2.1 Canada: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.2.2 Canada: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.2.3 Canada: Peripheral Embolization Coils Market Breakdown, by Application
  - 9.1.1.3 Mexico: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.3.1 Mexico: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.3.2 Mexico: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.3.3 Mexico: Peripheral Embolization Coils Market Breakdown, by Application

10. Peripheral Embolization Coils Market - Industry Landscape

10.1 Overview
10.2 Growth Strategies in the Peripheral Embolization Coils Market
10.3 Inorganic Growth Strategies
- 10.3.1 Overview
10.4 Organic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Medtronic Plc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Penumbra, Inc.
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Balt
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Boston Scientific Corp
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Cook Medical Holdings LLC
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Wallaby Medical
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Spartan Micro Inc.
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Terumo Corp
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments

12. Appendix

12.1 About The Insight Partners
12.2 Glossary of Terms